Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection-Reference-Cited by-同舟云学术

Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection

Published:2020-10 Issue: Volume:130 Page:110592
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

de Souza P.C.,Fernandes G.F.S.,Marino L.B.,Ribeiro C.M.,Silva P.B. da,Chorilli M.,Silva C.S.P.,Resende F.A.,Solcia M.C.,de Grandis R.A.,Costa C.A.S.,Cho S.H.,Wang Y.,Franzblau S.G.,dos Santos J.L.,Pavan F.R.

Funder

São Paulo Research Foundation

National Council for Scientific and Technological Development

Productivity Research Fellows

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil

USA National Institute of Allergy and Infections Diseases

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference39 articles.

1. World Health Organization (WHO). Global Tuberculosis Report 2019,2019

2. Advances in the development of new tuberculosis drugs and treatment regimens;Zumla;Nat. Rev. Drug Discov.,2013

3. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa;Klopper;Emerg Infect Dis,2013

4. Multidrug and Extensively Drug-resistant TB (M/XDR-TB);World Health Organization,2010

5. Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis;Dartois;Curr. Clin. Pharmacol.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Furan-based polymer: evaluating the cytogenotoxic profile from starting materials to the final product;Polymer Bulletin;2024-06-24

2. Overview of the effects and mechanisms of NO and its donors on biofilms;Critical Reviews in Food Science and Nutrition;2023-11-09

3. Regioselective Synthesis of NO-Donor (4-Nitro-1,2,3-triazolyl)furoxans via Eliminative Azide–Olefin Cycloaddition;Molecules;2023-10-07

4. Tuberculosis Drug Discovery: Challenges and New Horizons;Journal of Medicinal Chemistry;2022-05-25

5. Cyrhetrenyl and cymantrenyl N-acylhydrazone complexes based on isoniazid: Synthesis, characterization, X-ray crystal structures and antitubercular activity evaluation;Journal of Organometallic Chemistry;2022-04